Philippe Wolgen
Chief Executive Officer bij CLINUVEL PHARMACEUTICALS LIMITED
Vermogen: 31 M $ op 29-02-2024
Profiel
Philippe Jacques Wolgen occupies the position of Chief Executive Officer, MD & Director at Clinuvel Pharmaceuticals Ltd.
He is also on the board of Clinuvel (UK) Ltd.
He received an MBA from The Trustees of Columbia University in The City of New York, a doctorate from the University of Utrecht and an MBA from London Business School.
Bekende belangen in openbare bedrijven
Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
---|---|---|---|---|
24-11-2023 | 3 425 222 ( 6.83% ) | 31 M $ | 29-02-2024 |
Actieve functies van Philippe Wolgen
Bedrijven | Functie | Begin |
---|---|---|
CLINUVEL PHARMACEUTICALS LIMITED | Chief Executive Officer | 01-11-2005 |
Clinuvel (UK) Ltd.
Clinuvel (UK) Ltd. BiotechnologyHealth Technology Part of Clinuvel Pharmaceuticals Ltd., Clinuvel (UK) Ltd. is a British company founded in 2005 that provides research and development in the field of biotechnology. The private company is based in London, UK. | Director/Board Member | 25-11-2005 |
Opleiding van Philippe Wolgen
The Trustees of Columbia University in The City of New York | Masters Business Admin |
University of Utrecht | Doctorate Degree |
London Business School | Masters Business Admin |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 1 |
---|---|
CLINUVEL PHARMACEUTICALS LIMITED | Health Technology |
Bedrijven in privébezit | 1 |
---|---|
Clinuvel (UK) Ltd.
Clinuvel (UK) Ltd. BiotechnologyHealth Technology Part of Clinuvel Pharmaceuticals Ltd., Clinuvel (UK) Ltd. is a British company founded in 2005 that provides research and development in the field of biotechnology. The private company is based in London, UK. | Health Technology |